BIOTRICITY INC. (OTCMKTS:BTCY) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

BIOTRICITY INC. (OTCMKTS:BTCY) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Story continues below

Item 5.03

Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year

On April 21, 2017, the Board of Directors of Biotricity Inc.
(the Registrant) authorized the changing of the Registrants
fiscal year-end from December 31 to March 31. The audited
financial statements for the new fiscal year will be reflected
in the Registrants Transition Report on Form 10-K for the
transition period ended March 31, 2017.

Item 7.01

Regulation FD Disclosure

On April 25, 2017, the Registrant issued a press release
announcing that it changed its fiscal year-end from December 31
to March 31.

A copy of the press release is furnished as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated herein by
reference. The information in this Item 7.01 and in Item 9.01
of this report (including Exhibit 99.1) is being furnished to
Item 7.01 and shall not be deemed to be filed for the purposes
of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that
section. This report will not be deemed an admission as to the
materiality of any information herein (including Exhibit 99.1).

Item 9.01

Financial Statements and Exhibits

(d)

Exhibits. The exhibit listed in the following Exhibit
Index is furnished as part of this Current Report on Form 8-K:

Exhibit No.

Description

99.1

Press Release


About BIOTRICITY INC. (OTCMKTS:BTCY)

Biotricity Inc is a Canada-based medical technology company. The Company delivers remote biometric monitoring solutions, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. It offers bioflux, an Electrocardiogram (ECG) monitoring system that enables physicians to diagnose cardiovascular diseases or coronary heart diseases, acts as an ambulatory monitor that detects arrhythmias, performs remote mobile cardiac telemetry diagnostic monitoring, and transmits ECG data via a built-in cellular radio in real time. The Company also provides biolife, a health and lifestyle solution for individuals, which consists of a device that monitors heart-rhythm or ECG, as well as respiration, calories, temperature, physical activity, and other.

BIOTRICITY INC. (OTCMKTS:BTCY) Recent Trading Information

BIOTRICITY INC. (OTCMKTS:BTCY) closed its last trading session up +0.03 at 2.65 with 560 shares trading hands.

An ad to help with our costs